<DOC>
	<DOCNO>NCT01212406</DOCNO>
	<brief_summary>Vitamin D deficiency occur around 50 % transplant population . Preventive treatment Vitamin D ( D-cure ) reduce prevalence Bronchiolitis Obliterans Syndrome lung transplantation</brief_summary>
	<brief_title>Vitamin D Bronchiolitis Obliterans Syndrome</brief_title>
	<detailed_description>- Prospective , interventional , randomize , double-blind , placebo-controlled trial . - Clinical setting ( tertiary University Hospital ) . - Investigator-driven , pharmaceutical sponsor . - Lung transplant recipient . - Add-on study-drug ( placebo vitamin D ) 'standard care ' ( standardize , routine immunosuppressive infectious prophylactic protocol ) . - 1:1 inclusion ratio ( placebo : Vitamin D ) . - Randomisation discharge informed consent .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Stable LTx recipient discharge transplantation . Signed informed consent Adult ( age least 18 year old moment transplantation ) Able take oral medication Prolonged and/or complicate Intensive care unitcourse transplantation . Early ( &lt; 30 day posttransplant ) postoperative death Major suture problem ( airway stenosis stent ) Retransplantation ( lung ) Previous transplantation ( solid organ ) Multiorgan transplantation ( lung+ solid organ )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Organ rejection</keyword>
	<keyword>Lung transplantation</keyword>
	<keyword>Bronchiolitis Obliterans</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Prevention</keyword>
</DOC>